Aurinia Pharmaceuticals Inc (AUPH)
EBITDA Margin
65.57%
Quarterly · Period ending:
AUPH EBITDA Margin
Latest reported65.57%period ending
Latest reported65.57%period ending
AUPH Quarterly EBITDA Margin (-33.33% → 65.57%)
Quarterly ebitda margin
High-resolution chart · PNG
AUPH ebitda margin history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Margin |
|---|---|
| -499.4192% | |
| -837.1569% | |
| -572.4797% | |
| -2,500.003% | |
| -275.0006% | |
| -98.9762% | |
| -0.4537% | |
| -149.4365% | |
| -33.3333% |